ibi351
innovent biologics
['solid tumor', 'innovent']
sfbn feed: innovent presents clinical data of phase i study for ibi351 (kras g12c inhibitor) as monotherapy for solid tumors at the 2022 american society of clinical oncology (asco) annual meeting: san ... #bayarea #biotech 
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs